{
  "nct_id": "NCT72348905",
  "indication": "Non-Small Cell Lung Cancer",
  "phase": "Phase 2/3",
  "sample_size": 329,
  "duration_weeks": 51,
  "dropout_rate": 0.13,
  "blinding": "open-label",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "Overall survival"
  ],
  "secondary_endpoints": [
    "Objective response rate"
  ],
  "outcome_summary": "Benefit-risk profile does not support further development",
  "success": 0,
  "failure_reason": "Inadequate statistical power",
  "start_date": "2024-01-02",
  "completion_date": "2024-12-24"
}